What is the address of Fund+?

The registered office of Fund+ is located at Groot Begijnhof 60 box 1, 3000 Leuven.

Is Fund+ still active?

Yes. According to the CBE (29 October 2026) Fund+ is active, legal situation “Normale toestand”, started on 7 May 2015.

Is Fund+ registered on Peppol?

Yes, Fund+ is registered on the Peppol network with ID 0208:0629896521.

What is the enterprise number of Fund+?

The enterprise number of Fund+ is BE0629896521.

When was Fund+ founded?

Fund+ was founded on 7 May 2015.

Who are the directors of Fund+?

According to the 2025 annual accounts, the directors of Fund+ are: Luc Debruyne, Chris Buyse, François Fontaine, LGP Advisory BV, Dr. Ir. U. Vandeurzen Management Firm NV.

Is Fund+ a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 7 May 2015; 5 annual accounts filed, latest fiscal year 2025; 5 directors known from the annual account.

How much profit did Fund+ make in 2025?

Fund+ recorded a loss after taxes of € 1,768,019 in financial year 2025.

What is the revenue of Fund+?

As a small company, Fund+ is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -1,313,569.

How much does an employee at Fund+ earn?

The average wage cost per full-time employee at Fund+ was € 260,100 in 2025: staff costs of € 260,072 for 1 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Fund+ have?

According to the 2025 annual accounts, Fund+ has 1 full-time equivalents (FTE).

Fund+ (Public Limited) - Leuven - BE0629896521

Q: What does Fund+ do?

Fund+ is registered with the CBE as active in: Activiteiten van geldmarkt- en niet-geldmarktbeleggingsfondsen. Public Limited, started on 7 May 2015, 1 establishment.

Dossier Fund+, printed on 29 October 2026 from databakkes.be/en/0629896521/fund. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Fund+ from Leuven, company number BE0629896521, closed financial year 2025 with a result of € -1.8 million after tax. For that financial year Fund+ recorded a gross margin of € -1.3 million and equity of € 124 million. Compared with financial year 2024, the result moved from € 2.3 million to € -1.8 million. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 9, 2026.

What it is worth Growing

€ 124 million

▲ 2% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -1.8 million

▼ still € 2.3 million profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 4.2 million

▼ 50% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 17.1 million.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 260,072

▲ 34% vs 2024

€ 260,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 6,475

▼ 22% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 20,257

▼ 93% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 23,561

▲ 18% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	-	-	€ 1,695 Revenue 2024: € 1,695 First fiscal year in the series	-
Gross margin	€ -2,315,201 Gross margin 2022: € -2,315,201 First fiscal year in the series	€ -2,735,814 Gross margin 2023: € -2,735,814 ▼ € 420,613 vs 2022 (€ -2,315,201) Unfavourable step	€ -1,927,170 Gross margin 2024: € -1,927,170 ▲ € 808,644 vs 2023 (€ -2,735,814) Favourable step	€ -1,313,569 Gross margin 2025: € -1,313,569 ▲ € 613,601 vs 2024 (€ -1,927,170) Favourable step	▲ € 613,601
Profit after taxes	€ -4,280,052 Profit after taxes 2022: € -4,280,052 First fiscal year in the series	€ 17,178,847 Profit after taxes 2023: € 17,178,847 ▲ € 21.5 million vs 2022 (€ -4,280,052) Favourable step	€ 2,289,239 Profit after taxes 2024: € 2,289,239 ▼ 87% vs 2023 (€ 17,178,847) Unfavourable step	€ -1,768,019 Profit after taxes 2025: € -1,768,019 ▼ € 4.1 million vs 2024 (€ 2,289,239) Unfavourable step	▼ € 4.1 million
Equity	€ 119,593,001 Equity 2022: € 119,593,001 First fiscal year in the series	€ 118,985,756 Equity 2023: € 118,985,756 ▼ 1% vs 2022 (€ 119,593,001) Unfavourable step	€ 121,274,995 Equity 2024: € 121,274,995 ▲ 2% vs 2023 (€ 118,985,756) Favourable step	€ 124,005,976 Equity 2025: € 124,005,976 ▲ 2% vs 2024 (€ 121,274,995) Favourable step	▲ 2%
Total debts	€ 245,208 Total debts 2022: € 245,208 First fiscal year in the series	€ 24,541,612 Total debts 2023: € 24,541,612 ▲ € 24.3 million vs 2022 (€ 245,208) Unfavourable step	€ 1,736,272 Total debts 2024: € 1,736,272 ▼ 93% vs 2023 (€ 24,541,612) Favourable step	€ 98,832 Total debts 2025: € 98,832 ▼ 94% vs 2024 (€ 1,736,272) Favourable step	▼ 94%
Cash	€ 678,459 Cash 2022: € 678,459 First fiscal year in the series	€ 1,645,536 Cash 2023: € 1,645,536 ▲ 143% vs 2022 (€ 678,459) Favourable step	€ 8,258,827 Cash 2024: € 8,258,827 ▲ € 6.6 million vs 2023 (€ 1,645,536) Favourable step	€ 4,158,157 Cash 2025: € 4,158,157 ▼ 50% vs 2024 (€ 8,258,827) Unfavourable step	▼ 50%
Retained profit	€ 17,153,383 Retained profit 2022: € 17,153,383 First fiscal year in the series	€ 16,546,138 Retained profit 2023: € 16,546,138 ▼ 4% vs 2022 (€ 17,153,383) Unfavourable step	€ 18,835,377 Retained profit 2024: € 18,835,377 ▲ 14% vs 2023 (€ 16,546,138) Favourable step	€ 17,067,358 Retained profit 2025: € 17,067,358 ▼ 9% vs 2024 (€ 18,835,377) Unfavourable step	▼ 9%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 17,786,093 Dividend 2023: € 17,786,093 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 17,786,093) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 5,500,000 Bank debt 2023: € 5,500,000 Unchanged (€ 0) Unfavourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 5,500,000) Favourable step	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 119,838,209 Balance sheet total 2022: € 119,838,209 First fiscal year in the series	€ 143,527,368 Balance sheet total 2023: € 143,527,368 ▲ 20% vs 2022 (€ 119,838,209) Unchanged	€ 123,011,267 Balance sheet total 2024: € 123,011,267 ▼ 14% vs 2023 (€ 143,527,368) Unchanged	€ 124,104,807 Balance sheet total 2025: € 124,104,807 ▲ 1% vs 2024 (€ 123,011,267) Unchanged	▲ 1%
Employees (FTE)	1.3 Employees (FTE) 2022: 1.3 First fiscal year in the series	1.7 Employees (FTE) 2023: 1.7 ▲ 0.4 vs 2022 (1.3) Unchanged	1 Employees (FTE) 2024: 1 ▼ 0.7 vs 2023 (1.7) Unchanged	1 Employees (FTE) 2025: 1 Unchanged (1) Unchanged

Key figures of Fund+, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Fund+?

What happened at Fund+ in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2028 Luc Debruyne stepped down as director. NBB
2028 Chris Buyse stepped down as director. NBB
2028 François Fontaine stepped down as director. NBB
2028 LGP Advisory BV stepped down as director. NBB
2028 Dr. Ir. U. Vandeurzen Management Firm NV stepped down as director. NBB
Jun 9, 2026 New annual accounts for financial year 2025: loss of € 1.8 million (▼ € 4.1 million vs 2024). Source: NBB ↗
2024 Chris Buyse became a director. NBB
2024 Luc Debruyne became a director. NBB

In short

From € 4.3 million loss in 2022 to € 1.8 million loss in 2025.

Paid € 5,924 in corporate taxes since 2022.

Best year ever: 2023, with € 17.2 million profit.

Paid out € 17.8 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT 19.5%

VF Capital 13.1%

MULTIFIN 12.3%

The stake of SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT, VF Capital, MULTIFIN comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Fund+

ETHERNA IMMUNOTHERAPIES 31.2%

Confo Therapeutics 22.8%

Octimet Oncology NV 20.2%

Novadip Biosciences 20.1%

+14

The shares are held by SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT (19.5%), VF Capital (13.1%) and MULTIFIN (12.3%). It owns 31.2% of ETHERNA IMMUNOTHERAPIES, 22.8% of Confo Therapeutics, 20.2% of Octimet Oncology NV, 20.1% of Novadip Biosciences, 19.9% of Aelin Therapeutics NV and 19.6% of Ona Therapeutics itself.